NSYE, OTC: CO, CORBF

Global Cord Blood Corporation

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Global Cord Blood Corporation  (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2024.

If you purchased Global Cord securities and would like to join the action, please click “Join This Class Action.”

Class Period:June 4, 2019 through May 3, 2022

Deadline:

50 Days
If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that:

  • Global Cord employed a capital allocation strategy designed to reserve funds for Global Cord insiders and related parties rather than for the benefit of Global Cord shareholders;
  • Global Cord’s decisions to reject multiple going private offers and enter into the Transaction, an agreement to acquire Cellenkos Inc. for over $1 billion (including in Global Cord shares) were nothing more than self-serving and conflicted attempts by defendants to divert company funds to corporate insiders and related parties;
  • defendants had fundamentally misrepresented to investors Global Cord’s approach to capital allocation, strategic investments, acquisitions, and related party transactions as a result of the misappropriation by defendant Yuen Kam and his entities of hundreds of millions of dollars from Global Cord; and
  • as a result, Global Cord’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Global Cord Blood Corporation
Stock Symbol: CO; CORBF
Class Period: June 4, 2019 through May 3, 2022
Court: United States District Court for the Southern District of New York

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top